TY - JOUR AU - Chowdhury, P. S. AU - Chamoto, K. AU - Honjo, T. PY - 2017 DA - 2017// TI - Combination therapy strategies for improving PD-1 blockade efficacy: A new era in cancer immunotherapy JO - J Intern Med UR - https://doi.org/10.1111/joim.12708 DO - 10.1111/joim.12708 ID - Chowdhury2017 ER - TY - JOUR AU - Khunger, M. AU - Hernandez, A. V. AU - Pasupuleti, V. PY - 2017 DA - 2017// TI - Programmed cell death 1 (PD-1) ligand (PD-L1) expression in solid tumors as a predictive biomarker of benefit from PD-1/PD-L1 axis inhibitors: a systematic review and meta-analysis JO - JCO Precis Oncol UR - https://doi.org/10.1200/po.16.00030 DO - 10.1200/po.16.00030 ID - Khunger2017 ER - TY - JOUR AU - Dijkstra, K. K. AU - Voabil, P. AU - Schumacher, T. N. PY - 2016 DA - 2016// TI - Genomics- and transcriptomics-based patient selection for cancer treatment with immune checkpoint inhibitors: a review JO - JAMA Oncol VL - 2 UR - https://doi.org/10.1001/jamaoncol.2016.2214 DO - 10.1001/jamaoncol.2016.2214 ID - Dijkstra2016 ER - TY - JOUR AU - Chalmers, Z. R. AU - Connelly, C. F. AU - Fabrizio, D. PY - 2017 DA - 2017// TI - Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden JO - Genome Med VL - 9 UR - https://doi.org/10.1186/s13073-017-0424-2 DO - 10.1186/s13073-017-0424-2 ID - Chalmers2017 ER - TY - JOUR AU - Balar, A. V. AU - Weber, J. S. PY - 2017 DA - 2017// TI - PD-1 and PD-L1 antibodies in cancer: current status and future directions JO - Cancer Immunol Immunother VL - 66 UR - https://doi.org/10.1007/s00262-017-1954-6 DO - 10.1007/s00262-017-1954-6 ID - Balar2017 ER - TY - JOUR AU - Zou, W. AU - Wolchok, J. D. AU - Chen, L. PY - 2016 DA - 2016// TI - PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations JO - Sci Transl Med VL - 8 UR - https://doi.org/10.1126/scitranslmed.aad7118 DO - 10.1126/scitranslmed.aad7118 ID - Zou2016 ER - TY - JOUR AU - Cesano, A. AU - Warren, S. PY - 2018 DA - 2018// TI - Bringing the next generation of immuno-oncology biomarkers to the clinic JO - Biomedicines UR - https://doi.org/10.3390/biomedicines6010014 DO - 10.3390/biomedicines6010014 ID - Cesano2018 ER - TY - JOUR AU - Pagès, F. AU - Mlecnik, B. AU - Marliot, F. PY - 2018 DA - 2018// TI - International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study JO - Lancet VL - 391 UR - https://doi.org/10.1016/S0140-6736(18)30789-X DO - 10.1016/S0140-6736(18)30789-X ID - Pagès2018 ER - TY - JOUR AU - Markowiak, P. AU - Śliżewska, K. PY - 2018 DA - 2018// TI - The role of probiotics, prebiotics and synbiotics in animal nutrition JO - Gut Pathog VL - 10 UR - https://doi.org/10.1186/s13099-018-0250-0 DO - 10.1186/s13099-018-0250-0 ID - Markowiak2018 ER - TY - JOUR AU - Bin, L. AU - Yang, F. AU - Lu, D. PY - 2016 DA - 2016// TI - Specific immunotherapy plus Clostridium butyricum alleviates ulcerative colitis in patients with food allergy JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep25587 DO - 10.1038/srep25587 ID - Bin2016 ER - TY - JOUR AU - Shinnoh, M. AU - Horinaka, M. AU - Yasuda, T. PY - 2013 DA - 2013// TI - Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8 JO - Int J Oncol VL - 42 UR - https://doi.org/10.3892/ijo.2013.1790 DO - 10.3892/ijo.2013.1790 ID - Shinnoh2013 ER - TY - JOUR AU - Ford, A. C. AU - Quigley, E. M. AU - Lacy, B. E. PY - 2014 DA - 2014// TI - Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis JO - Am J Gastroenterol VL - 109 UR - https://doi.org/10.1038/ajg.2014.202 DO - 10.1038/ajg.2014.202 ID - Ford2014 ER - TY - JOUR AU - Gui, Q. F. AU - Lu, H. F. AU - Zhang, C. X. PY - 2015 DA - 2015// TI - Well-balanced commensal microbiota contributes to anti-cancer response in a lung cancer mouse model JO - Genet Mol Res VL - 14 UR - https://doi.org/10.4238/2015.May.25.16 DO - 10.4238/2015.May.25.16 ID - Gui2015 ER - TY - JOUR AU - Panebianco, C. AU - Andriulli, A. AU - Pazienza, V. PY - 2018 DA - 2018// TI - Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies JO - Microbiome VL - 6 UR - https://doi.org/10.1186/s40168-018-0483-7 DO - 10.1186/s40168-018-0483-7 ID - Panebianco2018 ER - TY - JOUR AU - Goubet, A. G. AU - Daillère, R. AU - Routy, B. PY - 2018 DA - 2018// TI - The impact of the intestinal microbiota in therapeutic responses against cancer JO - C R Biol VL - 341 UR - https://doi.org/10.1016/j.crvi.2018.03.004 DO - 10.1016/j.crvi.2018.03.004 ID - Goubet2018 ER - TY - JOUR AU - Iida, N. AU - Dzutsev, A. AU - Stewart, C. A. PY - 2013 DA - 2013// TI - Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment JO - Science VL - 342 UR - https://doi.org/10.1126/science.1240527 DO - 10.1126/science.1240527 ID - Iida2013 ER - TY - JOUR AU - Vétizou, M. AU - Pitt, J. M. AU - Daillère, R. PY - 2015 DA - 2015// TI - Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota JO - Science VL - 350 UR - https://doi.org/10.1126/science.aad1329 DO - 10.1126/science.aad1329 ID - Vétizou2015 ER - TY - JOUR AU - Sivan, A. AU - Corrales, L. AU - Hubert, N. PY - 2015 DA - 2015// TI - Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy JO - Science VL - 350 UR - https://doi.org/10.1126/science.aac4255 DO - 10.1126/science.aac4255 ID - Sivan2015 ER - TY - JOUR AU - Gopalakrishnan, V. AU - Spencer, C. N. AU - Nezi, L. PY - 2017 DA - 2017// TI - Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients JO - Science UR - https://doi.org/10.1126/science.aan4236 DO - 10.1126/science.aan4236 ID - Gopalakrishnan2017 ER - TY - JOUR AU - Routy, B. AU - Chatelier, E. AU - Derosa, L. PY - 2017 DA - 2017// TI - Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors JO - Science UR - https://doi.org/10.1126/science.aan3706 DO - 10.1126/science.aan3706 ID - Routy2017 ER - TY - JOUR AU - Matson, V. AU - Fessler, J. AU - Bao, R. PY - 2018 DA - 2018// TI - The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients JO - Science VL - 359 UR - https://doi.org/10.1126/science.aao3290 DO - 10.1126/science.aao3290 ID - Matson2018 ER - TY - JOUR AU - Kaderbhai, C. AU - Richard, C. AU - Fumet, J. D. PY - 2017 DA - 2017// TI - Antibiotic use does not appear to influence response to nivolumab JO - Anticancer Res VL - 37 ID - Kaderbhai2017 ER - TY - JOUR AU - Derosa, L. AU - Hellmann, M. D. AU - Spaziano, M. PY - 2018 DA - 2018// TI - Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer JO - Ann Oncol VL - 29 UR - https://doi.org/10.1093/annonc/mdy103 DO - 10.1093/annonc/mdy103 ID - Derosa2018 ER - TY - JOUR AU - Chaput, N. AU - Lepage, P. AU - Coutzac, C. PY - 2017 DA - 2017// TI - Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx108 DO - 10.1093/annonc/mdx108 ID - Chaput2017 ER - TY - JOUR AU - Frankel, A. E. AU - Coughlin, L. A. AU - Kim, J. PY - 2017 DA - 2017// TI - Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients JO - Neoplasia VL - 19 UR - https://doi.org/10.1016/j.neo.2017.08.004 DO - 10.1016/j.neo.2017.08.004 ID - Frankel2017 ER - TY - JOUR AU - Sharma, P. AU - Hu-Lieskovan, S. AU - Wargo, J. A. PY - 2017 DA - 2017// TI - Primary, adaptive, and acquired resistance to cancer immunotherapy JO - Cell VL - 168 UR - https://doi.org/10.1016/j.cell.2017.01.017 DO - 10.1016/j.cell.2017.01.017 ID - Sharma2017 ER - TY - JOUR AU - Botticelli, A. AU - Zizzari, I. AU - Mazzuca, F. PY - 2017 DA - 2017// TI - Cross-talk between microbiota and immune fitness to steer and control response to anti PD-1/PDL-1 treatment JO - Oncotarget VL - 8 ID - Botticelli2017 ER - TY - JOUR AU - Zitvogel, L. AU - Ayyoub, M. AU - Routy, B. PY - 2016 DA - 2016// TI - Microbiome and anticancer immunosurveillance JO - Cell VL - 165 UR - https://doi.org/10.1016/j.cell.2016.03.001 DO - 10.1016/j.cell.2016.03.001 ID - Zitvogel2016 ER - TY - JOUR AU - Yi, M. AU - Yu, S. AU - Qin, S. PY - 2018 DA - 2018// TI - Gut microbiome modulates efficacy of immune checkpoint inhibitors JO - J Hematol Oncol VL - 11 UR - https://doi.org/10.1186/s13045-018-0592-6 DO - 10.1186/s13045-018-0592-6 ID - Yi2018 ER - TY - JOUR AU - Routy, B. AU - Gopalakrishnan, V. AU - Daillère, R. PY - 2018 DA - 2018// TI - The gut microbiota influences anticancer immunosurveillance and general health JO - Nat Rev Clin Oncol VL - 15 UR - https://doi.org/10.1038/s41571-018-0006-2 DO - 10.1038/s41571-018-0006-2 ID - Routy2018 ER - TY - JOUR AU - Humphries, A. AU - Daud, A. PY - 2018 DA - 2018// TI - The gut microbiota and immune checkpoint inhibitors JO - Hum Vaccines Immunother UR - https://doi.org/10.1080/21645515.2018.1442970 DO - 10.1080/21645515.2018.1442970 ID - Humphries2018 ER - TY - JOUR AU - Gopalakrishnan, V. AU - Helmink, B. A. AU - Spencer, C. N. PY - 2018 DA - 2018// TI - The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy JO - Cancer Cell VL - 33 UR - https://doi.org/10.1016/j.ccell.2018.03.015 DO - 10.1016/j.ccell.2018.03.015 ID - Gopalakrishnan2018 ER - TY - JOUR AU - Zitvogel, L. AU - Ma, Y. AU - Raoult, D. PY - 2018 DA - 2018// TI - The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies JO - Science VL - 359 UR - https://doi.org/10.1126/science.aar6918 DO - 10.1126/science.aar6918 ID - Zitvogel2018 ER - TY - JOUR AU - Dubin, K. AU - Callahan, M. K. AU - Ren, B. PY - 2016 DA - 2016// TI - Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis JO - Nat Commun VL - 7 UR - https://doi.org/10.1038/ncomms10391 DO - 10.1038/ncomms10391 ID - Dubin2016 ER - TY - JOUR AU - Dziarski, R. AU - Park, S. Y. AU - Kashyap, D. R. PY - 2016 DA - 2016// TI - Pglyrp-regulated gut microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii enhance and Alistipes finegoldii attenuates colitis in mice JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0146162 DO - 10.1371/journal.pone.0146162 ID - Dziarski2016 ER - TY - JOUR AU - Lucke, K. AU - Miehlke, S. AU - Jacobs, E. PY - 2006 DA - 2006// TI - Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis JO - J Med Microbiol VL - 55 UR - https://doi.org/10.1099/jmm.0.46198-0 DO - 10.1099/jmm.0.46198-0 ID - Lucke2006 ER - TY - JOUR AU - Andoh, A. AU - Kuzuoka, H. AU - Tsujikawa, T. PY - 2012 DA - 2012// TI - Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease JO - J Gastroenterol VL - 47 UR - https://doi.org/10.1007/s00535-012-0605-0 DO - 10.1007/s00535-012-0605-0 ID - Andoh2012 ER - TY - JOUR AU - Neut, C. AU - Bulois, P. AU - Desreumaux, P. PY - 2002 DA - 2002// TI - Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn’s disease JO - Am J Gastroenterol VL - 97 UR - https://doi.org/10.1111/j.1572-0241.2002.05613.x DO - 10.1111/j.1572-0241.2002.05613.x ID - Neut2002 ER - TY - JOUR AU - Nguyen, T. L. AU - Vieira-Silva, S. AU - Liston, A. PY - 2015 DA - 2015// TI - How informative is the mouse for human gut microbiota research? JO - Dis Model Mech VL - 8 UR - https://doi.org/10.1242/dmm.017400 DO - 10.1242/dmm.017400 ID - Nguyen2015 ER - TY - JOUR AU - Ley, R. E. AU - Bäckhed, F. AU - Turnbaugh, P. PY - 2005 DA - 2005// TI - Obesity alters gut microbial ecology JO - Proc Natl Acad Sci USA VL - 102 UR - https://doi.org/10.1073/pnas.0504978102 DO - 10.1073/pnas.0504978102 ID - Ley2005 ER - TY - JOUR AU - Wiles, T. J. AU - Jemielita, M. AU - Baker, R. P. PY - 2016 DA - 2016// TI - Host gut motility promotes competitive exclusion within a model intestinal microbiota JO - PLoS Biol VL - 14 UR - https://doi.org/10.1371/journal.pbio.1002517 DO - 10.1371/journal.pbio.1002517 ID - Wiles2016 ER - TY - JOUR AU - Fessler, J. L. AU - Gajewski, T. F. PY - 2017 DA - 2017// TI - The microbiota: a new variable impacting cancer treatment outcomes JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-17-0864 DO - 10.1158/1078-0432.CCR-17-0864 ID - Fessler2017 ER - TY - JOUR AU - Rolig, A. S. AU - Parthasarathy, R. AU - Burns, A. R. PY - 2015 DA - 2015// TI - Individual members of the microbiota disproportionately modulate host innate immune responses JO - Cell Host Microbe VL - 18 UR - https://doi.org/10.1016/j.chom.2015.10.009 DO - 10.1016/j.chom.2015.10.009 ID - Rolig2015 ER - TY - JOUR AU - Letunic, I. AU - Bork, P. PY - 2016 DA - 2016// TI - Interactive tree of life (iTOL) v3: an online tool for the display and annotation of phylogenetic and other trees JO - Nucleic Acids Res VL - 44 UR - https://doi.org/10.1093/nar/gkw290 DO - 10.1093/nar/gkw290 ID - Letunic2016 ER -